Validity of first-time diagnoses of congenital epidermolysis bullosa in the Danish National Patient Registry and the Danish Pathology Registry

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Validity of first-time diagnoses of congenital epidermolysis bullosa in the Danish National Patient Registry and the Danish Pathology Registry. / Kristensen, Mattias Hedegaard; Schmidt, Sigrún Alba Jóhannesdóttir; Kibsgaard, Line; Mogensen, Mette; Sommerlund, Mette; Koppelhus, Uffe.

I: Clinical Epidemiology, Bind 11, 01.2019, s. 115-124.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Kristensen, MH, Schmidt, SAJ, Kibsgaard, L, Mogensen, M, Sommerlund, M & Koppelhus, U 2019, 'Validity of first-time diagnoses of congenital epidermolysis bullosa in the Danish National Patient Registry and the Danish Pathology Registry', Clinical Epidemiology, bind 11, s. 115-124. https://doi.org/10.2147/CLEP.S184742

APA

Kristensen, M. H., Schmidt, S. A. J., Kibsgaard, L., Mogensen, M., Sommerlund, M., & Koppelhus, U. (2019). Validity of first-time diagnoses of congenital epidermolysis bullosa in the Danish National Patient Registry and the Danish Pathology Registry. Clinical Epidemiology, 11, 115-124. https://doi.org/10.2147/CLEP.S184742

Vancouver

Kristensen MH, Schmidt SAJ, Kibsgaard L, Mogensen M, Sommerlund M, Koppelhus U. Validity of first-time diagnoses of congenital epidermolysis bullosa in the Danish National Patient Registry and the Danish Pathology Registry. Clinical Epidemiology. 2019 jan.;11:115-124. https://doi.org/10.2147/CLEP.S184742

Author

Kristensen, Mattias Hedegaard ; Schmidt, Sigrún Alba Jóhannesdóttir ; Kibsgaard, Line ; Mogensen, Mette ; Sommerlund, Mette ; Koppelhus, Uffe. / Validity of first-time diagnoses of congenital epidermolysis bullosa in the Danish National Patient Registry and the Danish Pathology Registry. I: Clinical Epidemiology. 2019 ; Bind 11. s. 115-124.

Bibtex

@article{21fc9320bcc54e6db7517549150e1f5e,
title = "Validity of first-time diagnoses of congenital epidermolysis bullosa in the Danish National Patient Registry and the Danish Pathology Registry",
abstract = "Purpose: Congenital epidermolysis bullosa (CEB) is a group of rare monogenic genoderma-toses. Phenotypically, the diseases vary in both severity and dissemination, which complicates studies of their epidemiology. To investigate the potential of using the Danish National Patient Registry (DNPR) for epidemiological research on CEB, we examined the positive predictive value (PPV) of a first-time diagnosis of CEB. Methods: We identified patients with a record of CEB in DNPR and the Danish Pathology Registry (DPR) during January 1, 1977, until December 31, 2015. We restricted diagnoses from two dermatological departments and one regional hospital. Diagnoses in the DNPR are coded by the eighth and tenth revisions of the ICD (ICD-8 and ICD-10) and in the DPR by the Systematized Nomenclature of Medicine (SNOMED). We used clinical description in medical records, family history, histological findings, and molecular genetic investigations to validate diagnoses and classified them as rejected and confirmed. We estimated PPVs for any diagnosis, according to coding systems used, and for additional subdivisions of ICD-10 codes. Results: We identified 116 cases from the hospital departments investigated and evaluated 96 medical records for validity. The overall PPV for probable CEB was 62.5% (95% CI: 52.5–71.5). For ICD-8, ICD-10, and SNOMED codes, the PPVs were 30.8% (95% CI: 11.4–57.7), 76.7% (95% CI: 65.8–84.9), and 0.0% (95% CI: 0.0–21.7), respectively. For the ICD-10 codes, we found the highest PPVs for diagnoses arising from the dermatological departments. For subdivisions of ICD-10 codes, PPVs were high for epidermolysis bullosa simplex and dystrophica. Conclusion: The PPVs for first-time diagnoses of CEB registered in the two Danish nationwide registries investigated, DNPR and DPR, ranged from low to average. We therefore recommend that these data be used with caution and restricted to ICD-10 diagnoses from specialized dermatological departments.",
keywords = "Denmark, Diagnosis, Epidermolysis bullosa, Health administrative data, Registration, Validity",
author = "Kristensen, {Mattias Hedegaard} and Schmidt, {Sigr{\'u}n Alba J{\'o}hannesd{\'o}ttir} and Line Kibsgaard and Mette Mogensen and Mette Sommerlund and Uffe Koppelhus",
year = "2019",
month = jan,
doi = "10.2147/CLEP.S184742",
language = "English",
volume = "11",
pages = "115--124",
journal = "Clinical Epidemiology",
issn = "1179-1349",
publisher = "Dove Medical Press Ltd",

}

RIS

TY - JOUR

T1 - Validity of first-time diagnoses of congenital epidermolysis bullosa in the Danish National Patient Registry and the Danish Pathology Registry

AU - Kristensen, Mattias Hedegaard

AU - Schmidt, Sigrún Alba Jóhannesdóttir

AU - Kibsgaard, Line

AU - Mogensen, Mette

AU - Sommerlund, Mette

AU - Koppelhus, Uffe

PY - 2019/1

Y1 - 2019/1

N2 - Purpose: Congenital epidermolysis bullosa (CEB) is a group of rare monogenic genoderma-toses. Phenotypically, the diseases vary in both severity and dissemination, which complicates studies of their epidemiology. To investigate the potential of using the Danish National Patient Registry (DNPR) for epidemiological research on CEB, we examined the positive predictive value (PPV) of a first-time diagnosis of CEB. Methods: We identified patients with a record of CEB in DNPR and the Danish Pathology Registry (DPR) during January 1, 1977, until December 31, 2015. We restricted diagnoses from two dermatological departments and one regional hospital. Diagnoses in the DNPR are coded by the eighth and tenth revisions of the ICD (ICD-8 and ICD-10) and in the DPR by the Systematized Nomenclature of Medicine (SNOMED). We used clinical description in medical records, family history, histological findings, and molecular genetic investigations to validate diagnoses and classified them as rejected and confirmed. We estimated PPVs for any diagnosis, according to coding systems used, and for additional subdivisions of ICD-10 codes. Results: We identified 116 cases from the hospital departments investigated and evaluated 96 medical records for validity. The overall PPV for probable CEB was 62.5% (95% CI: 52.5–71.5). For ICD-8, ICD-10, and SNOMED codes, the PPVs were 30.8% (95% CI: 11.4–57.7), 76.7% (95% CI: 65.8–84.9), and 0.0% (95% CI: 0.0–21.7), respectively. For the ICD-10 codes, we found the highest PPVs for diagnoses arising from the dermatological departments. For subdivisions of ICD-10 codes, PPVs were high for epidermolysis bullosa simplex and dystrophica. Conclusion: The PPVs for first-time diagnoses of CEB registered in the two Danish nationwide registries investigated, DNPR and DPR, ranged from low to average. We therefore recommend that these data be used with caution and restricted to ICD-10 diagnoses from specialized dermatological departments.

AB - Purpose: Congenital epidermolysis bullosa (CEB) is a group of rare monogenic genoderma-toses. Phenotypically, the diseases vary in both severity and dissemination, which complicates studies of their epidemiology. To investigate the potential of using the Danish National Patient Registry (DNPR) for epidemiological research on CEB, we examined the positive predictive value (PPV) of a first-time diagnosis of CEB. Methods: We identified patients with a record of CEB in DNPR and the Danish Pathology Registry (DPR) during January 1, 1977, until December 31, 2015. We restricted diagnoses from two dermatological departments and one regional hospital. Diagnoses in the DNPR are coded by the eighth and tenth revisions of the ICD (ICD-8 and ICD-10) and in the DPR by the Systematized Nomenclature of Medicine (SNOMED). We used clinical description in medical records, family history, histological findings, and molecular genetic investigations to validate diagnoses and classified them as rejected and confirmed. We estimated PPVs for any diagnosis, according to coding systems used, and for additional subdivisions of ICD-10 codes. Results: We identified 116 cases from the hospital departments investigated and evaluated 96 medical records for validity. The overall PPV for probable CEB was 62.5% (95% CI: 52.5–71.5). For ICD-8, ICD-10, and SNOMED codes, the PPVs were 30.8% (95% CI: 11.4–57.7), 76.7% (95% CI: 65.8–84.9), and 0.0% (95% CI: 0.0–21.7), respectively. For the ICD-10 codes, we found the highest PPVs for diagnoses arising from the dermatological departments. For subdivisions of ICD-10 codes, PPVs were high for epidermolysis bullosa simplex and dystrophica. Conclusion: The PPVs for first-time diagnoses of CEB registered in the two Danish nationwide registries investigated, DNPR and DPR, ranged from low to average. We therefore recommend that these data be used with caution and restricted to ICD-10 diagnoses from specialized dermatological departments.

KW - Denmark

KW - Diagnosis

KW - Epidermolysis bullosa

KW - Health administrative data

KW - Registration

KW - Validity

U2 - 10.2147/CLEP.S184742

DO - 10.2147/CLEP.S184742

M3 - Journal article

C2 - 30697082

AN - SCOPUS:85062698376

VL - 11

SP - 115

EP - 124

JO - Clinical Epidemiology

JF - Clinical Epidemiology

SN - 1179-1349

ER -

ID: 241488587